Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00107159 | Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma | completed | Phase 2 | 37 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00255762 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00395070 | A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma | completed | Phase 3 | 390 | VicalINDUSTRY | 14 | Sep 13, 2013 | clinicaltrials |
| NCT00498836 | Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma | completed | Phase 2 | 18 | Clavis PharmaINDUSTRY | 3 | Sep 12, 2013 | clinicaltrials |
| NCT00002952 | Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 20 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00004141 | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 46 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00004153 | Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma | completed | N/A | 106 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00203879 | Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma | completed | Phase 2 | 19 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01743157 | Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma(BBI) | completed | Phase 1 / Phase 2 | 24 | California Pacific Medical Center Research InstituteOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00246012 | A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma | completed | Phase 1 / Phase 2 | 144 | Centocor, Inc.INDUSTRY | 3 | Aug 19, 2013 | clinicaltrials |
| NCT00563823 | Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery | completed | Phase 2 | 34 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00707174 | Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna | completed | N/A | 90 | University of UtahOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00745862 | Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma | completed | — | 118 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00466687 | Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 34 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 22, 2013 | clinicaltrials |
| NCT00815607 | Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00003789 | Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg | completed | Phase 3 | 216 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT01011530 | Dose Escalation Study of MLN4924 in Adults With Melanoma | completed | Phase 1 | 37 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00948467 | Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies | completed | Phase 1 | 51 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00002535 | Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma | completed | Phase 2 | — | St. Luke's Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003568 | Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003792 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00039572 | Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain | completed | Phase 1 / Phase 2 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00059800 | Boron Neutron Capture Therapy in Treating Patients With Melanoma | completed | Phase 2 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00104897 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma | completed | Phase 2 | 25 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003346 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003362 | Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00287196 | Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes | completed | Phase 3 | 250 | Trans Tasman Radiation Oncology GroupOTHER | 4 | Jun 25, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00026520 | Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00042783 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019214 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019383 | Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019487 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019669 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019721 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019734 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00032045 | Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00058279 | Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00082914 | Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00416988 | Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants | completed | N/A | 1,135 | Rhode Island HospitalOTHER | 0 | Jun 20, 2013 | clinicaltrials |
| NCT00005633 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005815 | Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00019994 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020358 | Vaccine Therapy in Treating Patients With Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020397 | Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00021164 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 6, 2013source: clinicaltrials